Ellenbogen Michael 4
4 · Evolv Technologies Holdings, Inc. · Filed Jan 20, 2026
Insider Transaction Report
Form 4
Ellenbogen Michael
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2026-01-16$0.24/sh+80,745$19,379→ 2,164,706 total - Sale
Class A Common Stock
[F1][F2]2026-01-16$6.20/sh−80,745$500,619→ 2,083,961 total - Exercise/Conversion
Stock Option (Right to Buy)
[F3]2026-01-16−80,745→ 1,300,739 totalExercise: $0.24Exp: 2027-09-13→ Class A Common Stock (80,745 underlying)
Holdings
- 151,135(indirect: By Trust)
Class A Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.13 to $6.37. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.
Signature
/s/ Rachel Roy, Attorney-in-fact for Michael Ellenbogen|2026-01-20